Statistics for Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study
Total visits
| views | |
|---|---|
| Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study | 0 |
Total visits per month
| views | |
|---|---|
| December 2024 | 0 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| java.util.UUID:ee795af4-54db-46d1-80fc-a3aad8fd4219 | 13 |
| java.util.UUID:10f58697-9065-4df2-af39-5ac3fffc741e | 8 |
| Habib2024Efficacy-CCBY.pdf | 2 |
| java.util.UUID:f053da38-ef16-447f-b300-4012c1bbd19f | 2 |